Solitary Fibrous Tumor of the Pleura: Surgical Treatment and Recurrence

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

Background Solitary fibrous tumors of the pleura (SFTPs) are primary pleural tumors originating from the mesenchymal tissue. Surgical treatment was the first choice for management of SFTPs. There were no defined guidelines for the follow-up of these tumors and the postoperative therapy due to the rarity of these tumors.

Methods We conducted a retrospective, multicenter study from two high-volume centers in Italy. Data of patients diagnosed with pleural solitary fibrous tumors between January 2003 and October 2022 were prospectively recorded and retrospectively analyzed. The aim of this study was to identify predictive prognostic factors and the correlation between tumor characteristics and recurrence.

Results In all, 107 patients undergoing R0 surgical resection of pleural solitary fibrous tumor were included in the study. Patients were divided in two groups: benign and malignant. All the patients were treated with surgery with the aim to obtain R0 resection. Lung resection was necessary when the tumor adhered strongly to the lung parenchyma or infiltrated it. Twenty of the 107 patients had tumor recurrence. At a multivariate analysis, histological characteristics (high mitotic index) and maximum standardized uptake values (maxSUV) were related to recurrence. The mean disease-free survival (DFS) was 143.3 ± 6.1 months.

Conclusion In our experience, histological features of malignancy and maxSUV are significantly related to recurrence, which can occur even years after the first diagnosis. Surgical excision with negative surgical margins results in good long-term outcomes. After surgery, a long-term and strict follow-up should be done, in order to detect recurrence early. R0 of the recurrence is associated with long-term survival.

Publication History

Received: 11 June 2023

Accepted: 25 October 2023

Article published online:
27 November 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Wegner E. Das tuberkelahnliche lymphadenom (der cytogen oder reticulirte tuberkel). Arch Heilk (Leipzig) 1870; 11: 497
  PubMedGoogle Scholar
• 2 Klemperer P, Coleman BR. Primary neoplasms of the pleura. A report of five cases. Am J Ind Med 1992; 22 (01) 1-31
  CrossrefPubMedGoogle Scholar
• 3 Stout AP, Muray MR. Localized pleural mesothelioma. Arch Pathol (Chic) 1942; 34: 951-964
  PubMedGoogle Scholar
• 4 el-Naggar AK, Ro JY, Ayala AG, Ward R, Ordóñez NG. Localized fibrous tumor of the serosal cavities. Immunohistochemical, electron-microscopic, and flow-cytometric DNA study. Am J Clin Pathol 1989; 92 (05) 561-565
  CrossrefPubMedGoogle Scholar
• 5 England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989; 13 (08) 640-658
  CrossrefPubMedGoogle Scholar
• 6 Galateau-Salle F, Churg A, Roggli V, Travis WD. World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol 2016; 11 (02) 142-154
  CrossrefPubMedGoogle Scholar
• 7 Baldi GG, Stacchiotti S, Mauro V. et al. Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res 2013; 3: 4
  CrossrefPubMedGoogle Scholar
• 8 Yao MJ, Ding L, Atay SM. et al. A modern reaffirmation of surgery as the optimal treatment for solitary fibrous tumors of the pleura. Ann Thorac Surg 2019; 107 (03) 941-946
  CrossrefPubMedGoogle Scholar
• 9 Altinok T, Topçu S, Tastepe AI, Yazici U, Cetin G. Localized fibrous tumors of the pleura: clinical and surgical evaluation. Ann Thorac Surg 2003; 76 (03) 892-895
  CrossrefPubMedGoogle Scholar
• 10 Demicco EG, Park MS, Araujo DM. et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 2012; 25 (09) 1298-1306
  CrossrefPubMedGoogle Scholar
• 11 Cardillo G, Facciolo F, Cavazzana AO, Capece G, Gasparri R, Martelli M. Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg 2000; 70 (06) 1808-1812
  CrossrefPubMedGoogle Scholar
• 12 Kim DW, Na KJ, Yun JS, Song SY. Doege-potter syndrome: a report of a histologically benign but clinically malignant case. J Cardiothorac Surg 2017; 12 (01) 64
  CrossrefPubMedGoogle Scholar
• 13 Flores RM, Akhurst T, Gonen M. et al. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2006; 132 (04) 763-768
  CrossrefPubMedGoogle Scholar
• 14 Yeom YK, Kim MY, Lee HJ, Kim SS. Solitary fibrous tumors of the pleura of the thorax: CT and FDG PET characteristics in a tertiary referral center. Medicine (Baltimore) 2015; 94 (38) e1548
  CrossrefPubMedGoogle Scholar
• 15 Herrmann BL, Saller B, Kiess W. et al. Primary malignant fibrous histiocytoma of the lung: IGF-II producing tumor induces fasting hypoglycemia. Exp Clin Endocrinol Diabetes 2000; 108 (08) 515-518
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 2014; 27 (03) 390-395
  CrossrefPubMedGoogle Scholar
• 17 Bossart S, Rammlmair A, Haneke E. Reversible Schamroth sign after pleural tumor resection. Skin Appendage Disord 2019; 5 (05) 327-328
  CrossrefPubMedGoogle Scholar
• 18 Kamata T, Sakurai H, Nakagawa K, Watanabe S, Tsuta K, Asamura H. Solitary fibrous tumor of the pleura: morphogenesis and progression. A report of 36 cases. Surg Today 2015
  PubMedGoogle Scholar
• 19 Tapias LF, Mercier O, Ghigna MR. et al. Validation of a scoring system to predict recurrence of resected solitary fibrous tumors of the pleura. Chest 2015; 147 (01) 216-223
  CrossrefPubMedGoogle Scholar
• 20 de Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg 2002; 74 (01) 285-293
  CrossrefPubMedGoogle Scholar
• 21 Tapias LF, Mino-Kenudson M, Lee H. et al. Risk factor analysis for the recurrence of resected solitary fibrous tumours of the pleura: a 33-year experience and proposal for a scoring system. Eur J Cardiothorac Surg 2013; 44 (01) 111-117
  CrossrefPubMedGoogle Scholar
• 22 Liu WL, Wu W, Hong QC, Lv K. Recurrence rates of surgically resected solitary fibrous tumours of the pleura: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2021; 32 (06) 882-888
  CrossrefPubMedGoogle Scholar
• 23 Diebold M, Soltermann A, Hottinger S. et al. Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score: a multicenter study. Respir Res 2017; 18 (01) 210
  CrossrefPubMedGoogle Scholar
• 24 Akaike K, Kurisaki-Arakawa A, Hara K. et al. Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential. Hum Pathol 2015; 46 (03) 347-356
  CrossrefPubMedGoogle Scholar
• 25 Georgiesh T, Namløs HM, Sharma N. et al. Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour. Pathology 2021; 53 (06) 713-719
  CrossrefPubMedGoogle Scholar
• 26 Bylicki O, Rouvière D, Cassier P. et al. Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting. J Thorac Oncol 2015; 10 (02) 309-315
  CrossrefPubMedGoogle Scholar
• 27 Suter M, Gebhard S, Boumghar M, Peloponisios N, Genton CY. Localized fibrous tumours of the pleura: 15 new cases and review of the literature. Eur J Cardiothorac Surg 1998; 14 (05) 453-459
  CrossrefPubMedGoogle Scholar